MedTrace Logo

CPC in Adult Refractory Glaucoma

NCT04921098 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2022-01-11

No results posted yet for this study

Summary

The purpose of this study is to assess the relative effectiveness and safety of diode laser cyclophotocoagulation procedure to reduce IOP and relieve pain in adult patients with refractory glaucoma.

Conditions

  • Refractory Glaucoma

Interventions

PROCEDURE

Diode Laser Cyclophotocoagulation

A handpiece (G probe) is used to deliver the diode laser energy with a wavelength of 810 nm.

Sponsors & Collaborators

  • Sohag University

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-07-01
Primary Completion
2022-04-30
Completion
2022-04-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04921098 on ClinicalTrials.gov